Home
About
Overview
Sharing Data
ORCID
Help
History (19)
A Multifactorial Approach to Reduce Cardiovascular Disease in Type 2 Diabetes Mellitus: Now More Than Ever.
Safety, immunological effects and clinical response in a phase I trial of umbilical cord mesenchymal stromal cells in patients with treatment refractory SLE.
Spermine
Nephrostomy, Percutaneous
Zoledronic acid decreases bone formation without causing osteocyte death in mice.
See All 19 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Zoledronic acid decreases bone formation without causing osteocyte death in mice.
Zoledronic acid decreases bone formation without causing osteocyte death in mice. Arch Oral Biol. 2009 Sep; 54(9):851-6.
View in:
PubMed
subject areas
Alveolar Process
Animals
Bone Density Conservation Agents
Cell Death
Cell Survival
Diphosphonates
Femur
Fluoresceins
Fluorescent Dyes
Imidazoles
L-Lactate Dehydrogenase
Male
Mandible
Maxilla
Mice
Mice, Inbred C57BL
Osteocytes
Osteogenesis
Osteonecrosis
authors with profiles
Sarandeep Singh Huja